[
    [
        {
            "time": "2020-06-15",
            "original_text": "Coronavirus latest: Monday, June 15",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "latest",
                    "June 15"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Coronavirus latest: Monday, June 15",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 3,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Coronavirus update: U.S. death toll tops 115,000 amid growing worry about uptick in cases in Florida, Texas among others",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "update",
                    "U.S.",
                    "death",
                    "toll",
                    "Florida",
                    "Texas"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Coronavirus update: U.S. death toll tops 115,000 amid growing worry about uptick in cases in Florida, Texas among others",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Coronavirus update: US sees steady resurgence as FDA puts nail in coffin of hydroxychloroquine debate",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "update",
                    "US",
                    "resurgence",
                    "FDA",
                    "hydroxychloroquine"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Coronavirus update: US sees steady resurgence as FDA puts nail in coffin of hydroxychloroquine debate",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Eli Lilly Begins a Phase 3 Clinical Trial for a Potential COVID-19 Treatment",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Phase 3",
                    "Clinical Trial",
                    "COVID-19",
                    "Treatment"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Begins a Phase 3 Clinical Trial for a Potential COVID-19 Treatment",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Lilly Plans Trial of Arthritis Drug Against Covid-19",
            "features": {
                "keywords": [
                    "Lilly",
                    "Trial",
                    "Arthritis Drug",
                    "Covid-19"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Plans Trial of Arthritis Drug Against Covid-19",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Lilly Is Testing Its Arthritis Drug as a Coronavirus Treatment",
            "features": {
                "keywords": [
                    "Lilly",
                    "Testing",
                    "Arthritis Drug",
                    "Coronavirus"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Is Testing Its Arthritis Drug as a Coronavirus Treatment",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Lilly's shares drop as it enrolls first patient in COVID-19 study for arthritis drug",
            "features": {
                "keywords": [
                    "Lilly",
                    "shares",
                    "drop",
                    "COVID-19",
                    "study",
                    "arthritis drug"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly's shares drop as it enrolls first patient in COVID-19 study for arthritis drug",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Eli Lilly starts late-stage study of arthritis drug in COVID-19 patients",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "late-stage",
                    "study",
                    "arthritis drug",
                    "COVID-19"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly starts late-stage study of arthritis drug in COVID-19 patients",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "trial",
                    "rheumatoid arthritis drug",
                    "COVID-19"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients",
            "features": {
                "keywords": [
                    "Lilly",
                    "Phase 3",
                    "Clinical Trial",
                    "Baricitinib",
                    "Hospitalized",
                    "COVID-19"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]